Navegando por Autor "Fernandes, Fábio"

Agora exibindo 1 - 2 de 2
  • Nenhuma Miniatura disponível
    Item
    Atualização de Tópicos Emergentes da Diretriz Brasileira de Insuficiência Cardíaca – 2021
    (2021) Marcondes-Braga, Fabiana G.; Moura, Lídia Ana Zytynski; Issa, Victor Sarli; Vieira, Jefferson Luis; Rohde, Luis Eduardo; Simões, Marcus Vinícius; Fernandes-Silva, Miguel Morita; Rassi, Salvador; Alves, Silvia Marinho Martins; Albuquerque, Denilson Campos de; Almeida, Dirceu Rodrigues de; Bocchi, Edimar Alcides; Ramires, Felix José Alvarez; Bacal, Fernando; Rossi Neto, João Manoel; Danzmann, Luiz Claudio; Montera, Marcelo Westerlund; Oliveira Junior, Mucio Tavares de; Clausell, Nadine; Silvestre, Odilson Marcos; Bestetti, Reinaldo Bulgarelli; Bernadez-Pereira, Sabrina; Freitas Jr, Aguinaldo F.; Biolo, Andréia; Barretto, Antonio Carlos Pereira; Jorge, Antônio José Lagoeiro; Biselli, Bruno; Montenegro, Carlos Eduardo Lucena; Santos Júnior, Edval Gomes dos; Figueiredo, Estêvão Lanna; Fernandes, Fábio; Silveira, Fabio Serra; Atik, Fernando Antibas; Brito, Flávio de Souza; Souza, Germano Emílio Conceição; Ribeiro, Gustavo Calado de Aguiar; Villacorta, Humberto; Souza Neto, João David de; Goldraich, Livia Adams; Beck-da-Silva, Luís; Canesin, Manoel Fernandes; Bittencourt, Marcelo Imbroinise; Bonatto, Marcely Gimenes; Moreira, Maria da Consolação Vieira; Avila, Mônica Samuel; Coelho Filho, Otavio Rizzi; Schwartzmann, Pedro Vellosa; Mourilhe-Rocha, Ricardo; Mangini, Sandrigo; Ferreira, Silvia Moreira Ayub; Figueiredo Neto, José Albuquerque de; Mesquita, Evandro Tinoco
  • Nenhuma Miniatura disponível
    Item
    Does aortic valve repair in valve-sparing aortic root reconstruction compromise the longevity of the procedure?
    (2017) Dias, Ricardo Ribeiro; Duncan, José Augusto; de Souza Dinato, Fabrício José; Araújo, Lucas Lacerda; Issa, Hugo Monteiro Neder; Fernandes, Fábio; Mady, Charles; Jatene, Fábio Biscegli
    OBJECTIVES: The effect of performing aortic valve repair in combination with valve-sparing operation on the length of time for which patients are free from reoperation is unclear. The objective of this study was to determine if the performance of aortic valve repair during valve-sparing operation modified the freedom from reoperation time. METHODS: From January 2003 to July 2014, 78 patients with a mean age of 49±15 years underwent valve-sparing operation. Sixty-eight percent of these patients were male. Twenty-two (28%) aortic valve repair procedures were performed in this patient population. In the aortic valve repair + valve-sparing operation group, 77.3% of patients had moderate/severe aortic insufficiency, while in the valve-sparing operation group, 58.6% of patients had moderate/severe aortic insufficiency (ns = not significant). Additionally, 13.6% of patients in the aortic valve repair + valve-sparing operation group had functional class III/IV, while 14.2% of patients in the valve-sparing operation group had functional class III/IV (ns). RESULTS: The in-hospital and late mortality rates, for the aortic valve repair + valve-sparing operation and valve-sparing operation groups were similar, as they were 4.5% and 3.6%; and 0% and 1.8%, respectively. In the aortic valve repair + valve-sparing operation group, 0% of patients presented moderate/severe aortic insufficiency during late follow-up, while in the valve-sparing operation group, 14.2% of patients presented with moderate/severe aortic insufficiency during this period (ns). In the aortic valve repair + valve-sparing operation group, 5.3% of patients presented with functional class III/IV, while in the valve-sparing operation group, 4.2% of patients presented with functional class III/IV (ns). In the aortic valve repair + valve-sparing operation group, 0% of patients required reoperation, while in the valve-sparing operation group, 3.6% of patients required reoperation over a mean follow-up period of 1621±1156 days (75 patients). CONCLUSION: Valve-sparing operation is a safe and long-lasting procedure and performance of aortic valve repair when necessary does not increase risk of reoperation on the aortic valve.